AR226420A1 - Un procedimiento para preparar compuestos de s o o-isotioureido o isoureido-alquilen(c3-c8)-amino-5-piridilmetil-4-pirimidona - Google Patents

Un procedimiento para preparar compuestos de s o o-isotioureido o isoureido-alquilen(c3-c8)-amino-5-piridilmetil-4-pirimidona

Info

Publication number
AR226420A1
AR226420A1 AR277293A AR27729379A AR226420A1 AR 226420 A1 AR226420 A1 AR 226420A1 AR 277293 A AR277293 A AR 277293A AR 27729379 A AR27729379 A AR 27729379A AR 226420 A1 AR226420 A1 AR 226420A1
Authority
AR
Argentina
Prior art keywords
isoureid
isotioureid
pirimidone
piridyl
alkylene
Prior art date
Application number
AR277293A
Other languages
English (en)
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Application granted granted Critical
Publication of AR226420A1 publication Critical patent/AR226420A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AR277293A 1978-07-15 1979-07-13 Un procedimiento para preparar compuestos de s o o-isotioureido o isoureido-alquilen(c3-c8)-amino-5-piridilmetil-4-pirimidona AR226420A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7829999 1978-07-15

Publications (1)

Publication Number Publication Date
AR226420A1 true AR226420A1 (es) 1982-07-15

Family

ID=10498456

Family Applications (1)

Application Number Title Priority Date Filing Date
AR277293A AR226420A1 (es) 1978-07-15 1979-07-13 Un procedimiento para preparar compuestos de s o o-isotioureido o isoureido-alquilen(c3-c8)-amino-5-piridilmetil-4-pirimidona

Country Status (20)

Country Link
US (4) US4305945A (es)
EP (1) EP0007232A1 (es)
JP (1) JPS5515499A (es)
KR (1) KR830001247A (es)
AR (1) AR226420A1 (es)
AT (1) AT370728B (es)
AU (1) AU528878B2 (es)
CA (1) CA1114375A (es)
DD (1) DD144916A5 (es)
DK (1) DK293079A (es)
ES (1) ES482448A1 (es)
FI (1) FI792220A (es)
GR (1) GR69252B (es)
IL (1) IL57790A (es)
NO (1) NO792337L (es)
NZ (1) NZ191006A (es)
PH (1) PH15979A (es)
PL (1) PL217121A1 (es)
PT (1) PT69886A (es)
ZA (1) ZA793392B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN151188B (es) * 1978-02-13 1983-03-05 Smith Kline French Lab
AU527202B2 (en) * 1978-04-11 1983-02-24 Smith Kline & French Laboratories Limited 2-aminopyrimidones
ZA793392B (en) * 1978-07-15 1980-08-27 Smith Kline French Lab Isoureas and isothioureas
DK558181A (da) * 1981-01-30 1982-07-31 Smithkline Corp Fremgangsmaade til fremstilling af 3,5-diamino-1,2,4-triazoler
US4477663A (en) * 1981-02-06 1984-10-16 Smithkline Beckman Corporation Intermediates for preparing substituted pyrimidinones
US4620001A (en) * 1981-02-06 1986-10-28 Smithkline Beckman Corporation Chemical methods and intermediates for preparing substituted pyrimidinones
JPH0641454B2 (ja) * 1985-02-27 1994-06-01 日産化学工業株式会社 ピリダジノン誘導体
DE3532880A1 (de) * 1985-09-14 1987-03-26 Basf Ag 1,4-disubstituierte pyrazolderivate
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1223686A (en) 1967-02-24 1971-03-03 Ici Ltd Salts of pyrimidine derivatives and the use thereof as fungicides
US3980781A (en) * 1966-03-31 1976-09-14 Imperial Chemical Industries Limited Fungicidal composition and method containing 2-amino-pyrimidines
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
US4145546A (en) * 1975-10-02 1979-03-20 Smith Kline & French Laboratories Limited 4-Pyrimidone compounds
US4218452A (en) * 1975-10-02 1980-08-19 Smith Kline & French Laboratories Limited Substituted 4-pyrimidone compounds, compositions and methods of use
GB1578219A (en) * 1975-12-01 1980-11-05 Smith Kline French Lab Isothioureas
US4154834A (en) * 1975-12-29 1979-05-15 Smith Kline & French Laboratories Limited Substituted isocytosines having histamine H2 -antagonist activity
MW5076A1 (en) * 1975-12-29 1978-02-08 Smith Kline French Lab Pharmacologicalle active compounds
IN151188B (es) * 1978-02-13 1983-03-05 Smith Kline French Lab
ZA793392B (en) * 1978-07-15 1980-08-27 Smith Kline French Lab Isoureas and isothioureas

Also Published As

Publication number Publication date
US4305945A (en) 1981-12-15
CA1114375A (en) 1981-12-15
PT69886A (en) 1979-08-01
JPS5515499A (en) 1980-02-02
KR830001247A (ko) 1983-04-29
US4558128A (en) 1985-12-10
AT370728B (de) 1983-04-25
US4639519A (en) 1987-01-27
FI792220A (fi) 1980-01-16
DD144916A5 (de) 1980-11-12
NZ191006A (en) 1982-09-07
DK293079A (da) 1980-01-16
NO792337L (no) 1980-01-16
AU528878B2 (en) 1983-05-19
IL57790A (en) 1984-01-31
PL217121A1 (es) 1980-06-16
PH15979A (en) 1983-05-16
ES482448A1 (es) 1980-04-01
US4439435A (en) 1984-03-27
AU4895479A (en) 1980-01-24
IL57790A0 (en) 1979-11-30
ATA492279A (de) 1982-09-15
EP0007232A1 (en) 1980-01-23
GR69252B (es) 1982-05-11
ZA793392B (en) 1980-08-27

Similar Documents

Publication Publication Date Title
ES496948A0 (es) Un procedimiento para preparar compuestos de cefem
ES497084A0 (es) Un procedimiento para preparar nuevos compuestos de tiazol.
ES490503A0 (es) Un procedimiento para preparar nuevos compuestos de cefem
MX5973E (es) Procedimiento para preparar compuestos cefem
ES493061A0 (es) Un procedimiento para preparar un lipopolisacarido
ES490166A0 (es) Un procedimiento para preparar mercaptoacildipeptidos
AR225310A1 (es) Un procedimiento para preparar derivados de alquil(c3-c8)-cetohexopiranosidos
ES492032A0 (es) Procedimiento para preparar compuestos de cefem
ES487847A0 (es) Un procedimiento para preparar nuevas fenetanolaminas
ES492002A0 (es) Un procedimiento para preparar compuestos de cefem
ES486425A0 (es) Un procedimiento para preparar nuevas 4-arilpiperinas.
ES497302A0 (es) Un procedimiento para preparar 9-aminoalquilfluorenos
ES491221A0 (es) Un procedimiento para preparar un compuesto de 1,8-naftiri- dina
AR226420A1 (es) Un procedimiento para preparar compuestos de s o o-isotioureido o isoureido-alquilen(c3-c8)-amino-5-piridilmetil-4-pirimidona
ES494459A0 (es) Un procedimiento para preparar cetoximinoeteres
ES505496A0 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES493761A0 (es) Un procedimiento para preparar benzoxazepinas
ES496859A0 (es) Un procedimiento para preparar derivados de halofenil-piri- dilalilamina
ES486989A0 (es) Un procedimiento para preparar derivados de la 4- dehidropi-ridina.
AR226418A1 (es) Un procedimiento para preparar compuestos de 2,4-dicloro-piridina
ES489590A0 (es) Un procedimiento para preparar arilalquil- y ariloxi-alquil-fosfonatos
ES488808A0 (es) Un procedimiento para preparar derivados de fenotiazina
ES505714A0 (es) Un procedimiento para preparar compuestos de cefem
ES487010A0 (es) Un procedimiento para preparar derivados de acido-3-aril- isoxazol-5-ilbenzoico.
ES498168A0 (es) Un procedimiento para preparar alcohilfosfonoditioato de al-cohilo